NASDAQ:OGI Organigram (OGI) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free OGI Stock Alerts $1.84 -0.04 (-2.13%) (As of 11:38 AM ET) Add Compare Share Share Today's Range$1.84▼$1.9050-Day Range$1.76▼$2.7252-Week Range$0.97▼$2.91Volume225,189 shsAverage Volume1.40 million shsMarket Capitalization$190.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Organigram alerts: Email Address Organigram MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish5.87% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.46Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.32) to ($0.07) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.24 out of 5 starsMedical Sector897th out of 920 stocksPharmaceutical Preparations Industry421st out of 430 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Organigram.Read more about Organigram's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.87% of the float of Organigram has been sold short.Short Interest Ratio / Days to CoverOrganigram has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Organigram has recently increased by 7.82%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OGI. Previous Next 2.5 News and Social Media Coverage News SentimentOrganigram has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Organigram this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows5 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.09% of the stock of Organigram is held by insiders.Percentage Held by InstitutionsOnly 34.63% of the stock of Organigram is held by institutions.Read more about Organigram's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Organigram are expected to grow in the coming year, from ($0.32) to ($0.07) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is -1.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is -1.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.94. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Organigram's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Tomorrow InvestorU.S. Drone Company Receives DoD CertificationThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest About Organigram Stock (NASDAQ:OGI)Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.Read More OGI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OGI Stock News HeadlinesMay 18, 2024 | americanbankingnews.comAtb Cap Markets Weighs in on Organigram Holdings Inc.'s Q3 2024 Earnings (NASDAQ:OGI)May 17, 2024 | americanbankingnews.comOrganigram Holdings Inc. (NASDAQ:OGI) to Post Q3 2024 Earnings of ($0.04) Per Share, Alliance Global Partners ForecastsMay 14, 2024 | sfgate.comOrganiGram: Fiscal Q2 Earnings SnapshotMay 14, 2024 | msn.comOrganigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International MarketsMay 14, 2024 | businesswire.comOrganigram Reports Second Quarter Fiscal 2024 ResultsMay 8, 2024 | businesswire.comOrganigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024April 27, 2024 | investorplace.comThe Top 3 Cannabis Stocks to Buy in April 2024April 26, 2024 | finance.yahoo.comAre Medical Stocks Lagging OrganiGram (OGI) This Year?April 11, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)April 10, 2024 | stockhouse.comOrganigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive YearApril 3, 2024 | finance.yahoo.comOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesApril 3, 2024 | businesswire.comOrganigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesApril 2, 2024 | businesswire.comOrganigram Successfully Closes Previously Announced Underwritten Public OfferingMarch 27, 2024 | msn.comWhy OrganiGram (OGI) Stock Is DivingMarch 27, 2024 | businesswire.comOrganigram Announces Pricing of Overnight Marketed Public OfferingMarch 26, 2024 | businesswire.comOrganigram Announces Launch of Overnight Marketed Public OfferingMarch 26, 2024 | businesswire.comOrganigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter InvestmentMarch 26, 2024 | finance.yahoo.comOGI Sep 2024 6.000 callMarch 26, 2024 | finance.yahoo.comOGI Jun 2024 4.000 putMarch 22, 2024 | businesswire.comOrganigram Receives Health Canada's Final Redetermination on JoltsMarch 21, 2024 | investorplace.comFinding the Next Big Winners: 3 Stocks You Can Snag for Under $5March 17, 2024 | finance.yahoo.comOGI Apr 2024 2.000 putFebruary 28, 2024 | businesswire.comOrganigram Applauds the Standing Committee on Finance's Recommendation on Excise DutyFebruary 27, 2024 | proactiveinvestors.comOrganigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analystsFebruary 20, 2024 | investorplace.com3 Millionaire-Maker Cannabis Penny Stocks to Buy in February 2024See More Headlines Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today5/23/2024Next Earnings (Estimated)7/11/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:OGI CUSIPN/A CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees984Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.94) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-184,340,000.00 Net Margins-188.38% Pretax Margin-156.16% Return on Equity-40.19% Return on Assets-34.70% Debt Debt-to-Equity RatioN/A Current Ratio3.47 Quick Ratio1.98 Sales & Book Value Annual Sales$120.01 million Price / Sales1.62 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.96Miscellaneous Outstanding Shares103,370,000Free Float103,277,000Market Cap$194.34 million OptionableOptionable Beta1.07 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Beena G. Goldenberg (Age 60)CEO & Director Comp: $352.27kMs. Helen Martin (Age 46)Chief Legal Officer & Corporate Secretary Comp: $223.52kMr. Timothy EmbergChief Commercial OfficerMr. Paolo De Luca C.A. (Age 51)C.F.A, Chief Strategy Officer Comp: $222.62kMr. Greg Guyatt C.A.CPA, Chief Financial OfficerMs. Nathalie BattenSenior Vice President of OperationsMr. Geoff RiggsChief Information OfficerMax SchwartzDirector of Investor RelationsMs. Megan Amber McCraeSenior Vice President of Marketing & CommunicationsMs. Katrina May McFaddenChief People OfficerMore ExecutivesKey CompetitorsCapricor TherapeuticsNASDAQ:CAPRGalectin TherapeuticsNASDAQ:GALTPuma BiotechnologyNASDAQ:PBYIInventivaNASDAQ:IVAOmerosNASDAQ:OMERView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 158,331 shares on 5/20/2024Ownership: 0.153%Tidal Investments LLCBought 1,737,876 shares on 5/17/2024Ownership: 1.681%Murchinson Ltd.Bought 813,906 shares on 5/16/2024Ownership: 0.787%CVI Holdings LLCBought 383,528 shares on 5/7/2024Ownership: 0.371%View All Institutional Transactions OGI Stock Analysis - Frequently Asked Questions Should I buy or sell Organigram stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OGI shares. View OGI analyst ratings or view top-rated stocks. How have OGI shares performed in 2024? Organigram's stock was trading at $1.31 on January 1st, 2024. Since then, OGI stock has increased by 40.5% and is now trading at $1.84. View the best growth stocks for 2024 here. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 11th 2024. View our OGI earnings forecast. How were Organigram's earnings last quarter? Organigram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings data on Tuesday, May, 14th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.06. The firm earned $27.91 million during the quarter, compared to analysts' expectations of $28.27 million. Organigram had a negative net margin of 188.38% and a negative trailing twelve-month return on equity of 40.19%. When did Organigram's stock split? Shares of Organigram reverse split on the morning of Friday, July 7th 2023. The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), EVIO (EVIO) and Who are Organigram's major shareholders? Organigram's stock is owned by many different retail and institutional investors. Top institutional shareholders include Tidal Investments LLC (1.68%), Murchinson Ltd. (0.79%), CVI Holdings LLC (0.37%) and Virtu Financial LLC (0.15%). How do I buy shares of Organigram? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:OGI) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersDividend-like income from non-dividend stocksUnstoppable ProsperityMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeThis could mean the end of the U.S dollar…Colonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.